TD Cowen reiterates Outperform on Evolv after short seller response

TD Cowen notes that Evolv issued a press release this morning aimed at correcting misinformation the company says has been disseminated as part of a “short seller campaign” and refuted assertions raised as part of the campaign. The firm, which argues that Evolv is delivering strong unit growth and expanding profitability, reiterates an Outperform rating and $7 price target on the shares.